{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:12:23Z","timestamp":1782760343835,"version":"3.54.5"},"reference-count":132,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL086350"],"award-info":[{"award-number":["T32 HL086350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["TL1 TR001861"],"award-info":[{"award-number":["TL1 TR001861"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Small Animal Practice"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cvsm.2023.05.016","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T15:52:41Z","timestamp":1688745161000},"page":"1255-1276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Role of Personalized Medicine in Companion Animal Cardiology"],"prefix":"10.1016","volume":"53","author":[{"given":"Victor N.","family":"Rivas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cvsm.2023.05.016_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00059-020-04903-5","article-title":"Dilated cardiomyopathies and non-compaction cardiomyopathy","volume":"45","author":"H\u00e4nselmann","year":"2020","journal-title":"Herz"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1715","article-title":"Hypertrophic cardiomyopathy: the future of treatment","volume":"22","author":"Tuohy","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.14740\/cr578w","article-title":"Feline Hypertrophic Cardiomyopathy: A Spontaneous Large Animal Model of Human HCM","volume":"8","author":"Freeman","year":"2017","journal-title":"Cardiol Res"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.016_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ehf2.12267","article-title":"Genetic determinants of heart failure: facts and numbers","volume":"5","author":"Czepluch","year":"2018","journal-title":"ESC Heart Fail"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001620","article-title":"Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications","volume":"10","author":"Ingles","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/CRD.0b013e318178e525","article-title":"Hypertrophic cardiomyopathy: etiology, diagnosis, and treatment","volume":"16","author":"Ramaraj","year":"2008","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.cvsm.2023.05.016_bib7","doi-asserted-by":"crossref","first-page":"544162","DOI":"10.3389\/fgene.2020.544162","article-title":"Next Generation Sequencing and Bioinformatics Analysis of Family Genetic Inheritance","volume":"11","author":"Kanzi","year":"2020","journal-title":"Front Genet"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.016_bib8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrg2344","article-title":"Genome-wide association studies for complex traits: consensus, uncertainty and challenges","volume":"9","author":"McCarthy","year":"2008","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41436-019-0618-7","article-title":"The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom","volume":"22","author":"Schwarze","year":"2020","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2003.05.009","article-title":"Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults","volume":"116","author":"Zou","year":"2004","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.016_bib12","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0735-1097(99)00039-X","article-title":"Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities","volume":"33","author":"Maron","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.cvsm.2023.05.016_bib13","first-page":"1122","article-title":"Sudden cardiac death associated with occult hypertrophic cardiomyopathy in a dog under anesthesia","volume":"46","author":"Pang","year":"2005","journal-title":"Can Vet J"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.016_bib14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1292\/jvms.65.753","article-title":"Hypertrophic cardiomyopathy in an aged dog","volume":"65","author":"Washizu","year":"2003","journal-title":"J\u00a0Vet Med Sci"},{"issue":"23","key":"10.1016\/j.cvsm.2023.05.016_bib15","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/hmg\/ddi386","article-title":"A\u00a0cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy","volume":"14","author":"Meurs","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.016_bib16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-2836(03)00781-2","article-title":"Structural evidence for the interaction of C-protein (MyBP-C) with actin and sequence identification of a possible actin-binding domain","volume":"331","author":"Squire","year":"2003","journal-title":"J\u00a0Mol Biol"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.cr.7290208","article-title":"Myosin binding protein C: structural abnormalities in familial hypertrophic cardiomyopathy","volume":"14","author":"Oakley","year":"2004","journal-title":"Cell Res"},{"issue":"7","key":"10.1016\/j.cvsm.2023.05.016_bib18","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1074\/jbc.M008691200","article-title":"Hypercontractile properties of cardiac muscle fibers in a knock-in mouse model of cardiac myosin-binding protein-C","volume":"276","author":"Witt","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/jmbi.1999.3276","article-title":"COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and\/or incorporation in fetal rat cardiomyocytes","volume":"294","author":"Flavigny","year":"1999","journal-title":"J\u00a0Mol Biol"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygeno.2007.04.007","article-title":"A\u00a0substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy","volume":"90","author":"Meurs","year":"2007","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijcard.2010.04.032","article-title":"The R820W mutation in the MYBPC3 gene, associated with hypertrophic cardiomyopathy in cats, causes hypertrophic cardiomyopathy and left ventricular non-compaction in humans","volume":"145","author":"Ripoll Vera","year":"2010","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13023-021-01740-5","article-title":"A\u00a0deleterious mutation in the ALMS1 gene in a naturally occurring model of hypertrophic cardiomyopathy in the Sphynx cat","volume":"16","author":"Meurs","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2460\/javma.2002.220.202","article-title":"Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999)","volume":"220","author":"Rush","year":"2002","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.016_bib24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/jvim.16402","article-title":"Retrospective evaluation of hypertrophic cardiomyopathy in 68 dogs","volume":"36","author":"Schober","year":"2022","journal-title":"J\u00a0Vet Intern Med"},{"issue":"11","key":"10.1016\/j.cvsm.2023.05.016_bib25","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1177\/1098612X211020162","article-title":"The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy","volume":"23","author":"Kittleson","year":"2021","journal-title":"J\u00a0Feline Med Surg"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/jvim.12031","article-title":"Myosin-binding protein C DNA variants in domestic cats (A31P, A74T, R820W) and their association with hypertrophic cardiomyopathy","volume":"27","author":"Longeri","year":"2013","journal-title":"J\u00a0Vet Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2023.05.016_bib27","first-page":"S53","article-title":"The genetic basis of hypertrophic cardiomyopathy in cats and humans","volume":"17","author":"Kittleson","year":"2015","journal-title":"J\u00a0Vet Cardiol"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.016_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00001573-200205000-00006","article-title":"Modifier genes for hypertrophic cardiomyopathy","volume":"17","author":"Marian","year":"2002","journal-title":"Curr Opin Cardiol"},{"issue":"9","key":"10.1016\/j.cvsm.2023.05.016_bib29","first-page":"542","article-title":"Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy","volume":"45","author":"Brugada","year":"1997","journal-title":"J\u00a0Investig Med"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.016_bib30","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00424-018-2209-x","article-title":"Inherited cardiomyopathies in veterinary medicine","volume":"471","author":"Stern","year":"2019","journal-title":"Pflugers Arch"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib31","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1939-1676.2009.0341.x","article-title":"Analysis of 8 sarcomeric candidate genes for feline hypertrophic cardiomyopathy mutations in cats with hypertrophic cardiomyopathy","volume":"23","author":"Meurs","year":"2009","journal-title":"J\u00a0Vet Intern Med"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.016_bib32","doi-asserted-by":"crossref","first-page":"544","DOI":"10.5326\/15473317-33-6-544","article-title":"A\u00a0retrospective study of canine dilated cardiomyopathy (189 cases)","volume":"33","author":"Tidholm","year":"1997","journal-title":"J\u00a0Am Anim Hosp Assoc"},{"key":"10.1016\/j.cvsm.2023.05.016_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/jsap.12841","article-title":"An update on canine cardiomyopathies - is it all in the genes?","author":"Dutton","year":"2018","journal-title":"J\u00a0Small Anim Pract"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib34","first-page":"17","article-title":"Dilated cardiomyopathy in Doberman Pinschers: Survival, Causes of Death and a Pedigree Review in a Related Line","volume":"4","author":"Petric","year":"2002","journal-title":"J\u00a0Vet Cardiol"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.016_bib35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2460\/javma.2001.218.729","article-title":"Clinical features of dilated cardiomyopathy in Great Danes and results of a pedigree analysis: 17 cases (1990-2000)","volume":"218","author":"Meurs","year":"2001","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5326\/15473317-36-2-125","article-title":"The prevalence of cardiomyopathy in the Irish wolfhound: a clinical study of 500 dogs","volume":"36","author":"Vollmar","year":"2000","journal-title":"J\u00a0Am Anim Hosp Assoc"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.016_bib37","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1177\/0300985813480509","article-title":"Histological characterization of dilated cardiomyopathy in the juvenile toy Manchester terrier","volume":"50","author":"Legge","year":"2013","journal-title":"Vet Pathol"},{"key":"10.1016\/j.cvsm.2023.05.016_bib38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.gene.2019.02.022","article-title":"The R9H phospholamban mutation is associated with highly penetrant dilated cardiomyopathy and sudden death in a spontaneous canine model","volume":"697","author":"Yost","year":"2019","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5326\/JAAHA-MS-6506","article-title":"Dilated Cardiomyopathy in Standard Schnauzers: Retrospective Study of 15 Cases","volume":"53","author":"Harmon","year":"2017","journal-title":"J\u00a0Am Anim Hosp Assoc"},{"issue":"11","key":"10.1016\/j.cvsm.2023.05.016_bib40","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1177\/1098612X211030218","article-title":"The Feline Cardiomyopathies: 3. Cardiomyopathies other than HCM","volume":"23","author":"Kittleson","year":"2021","journal-title":"J\u00a0Feline Med Surg"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib41","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0735-1097(97)00434-8","article-title":"Frequency and phenotypes of familial dilated cardiomyopathy","volume":"31","author":"Grunig","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.cvsm.2023.05.016_bib42","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1354\/vp.42-1-1","article-title":"Histologic characterization of canine dilated cardiomyopathy","volume":"42","author":"Tidholm","year":"2005","journal-title":"Vet Pathol"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.053033","article-title":"Evidence-Based Assessment of Genes in Dilated Cardiomyopathy","volume":"144","author":"Jordan","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cvsm.2023.05.016_bib45","doi-asserted-by":"crossref","first-page":"204823","DOI":"10.1155\/2015\/204823","article-title":"Genetics of Human and Canine Dilated Cardiomyopathy","volume":"2015","author":"Simpson","year":"2015","journal-title":"Int J Genomics"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.016_bib46","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00439-019-01973-2","article-title":"A\u00a0missense variant in the titin gene in Doberman pinscher dogs with familial dilated cardiomyopathy and sudden cardiac death","volume":"138","author":"Meurs","year":"2019","journal-title":"Hum Genet"},{"issue":"8","key":"10.1016\/j.cvsm.2023.05.016_bib47","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00439-012-1158-2","article-title":"A\u00a0splice site mutation in a gene encoding for PDK4, a mitochondrial protein, is associated with the development of dilated cardiomyopathy in the Doberman pinscher","volume":"131","author":"Meurs","year":"2012","journal-title":"Hum Genet"},{"key":"10.1016\/j.cvsm.2023.05.016_bib48","unstructured":"Leach SB, Johnson GS, Gilliam D, et al. Dilated cardiomyopathy in standard schnauzers with a homozygous 22 bp deletion in RBM20. In: Proceedings of the 32nd ACVIM Forum. 2014. Nashville, TN, USA."},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/genes10020168","article-title":"A\u00a0QIL1 Variant Associated with Ventricular Arrhythmias and Sudden Cardiac Death in the Juvenile Rhodesian Ridgeback Dog","volume":"10","author":"Meurs","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.cvsm.2023.05.016_bib50","unstructured":"Oertle DT, Batcher KL, Stern JA, et al. Sudden death and cardiomyopathy associated with LMNA in the Nova Scotia Duck Tolling Retriever. In: Proceedings of the UC Davis Student Training in Advanced Research (STAR) Symposium. 2022."},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.016_bib51","doi-asserted-by":"crossref","first-page":"e36691","DOI":"10.1371\/journal.pone.0036691","article-title":"Multiple Loci are associated with dilated cardiomyopathy in Irish wolfhounds","volume":"7","author":"Philipp","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.016_bib52","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/jvim.12163","article-title":"Association of dilated cardiomyopathy with the striatin mutation genotype in boxer dogs","volume":"27","author":"Meurs","year":"2013","journal-title":"J\u00a0Vet Intern Med"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.016_bib53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0960-8966(99)00011-5","article-title":"Molecular analysis of a spontaneous dystrophin 'knockout' dog","volume":"9","author":"Schatzberg","year":"1999","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.016_bib54","first-page":"255","article-title":"A\u00a0double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy","volume":"16","author":"Fuentes","year":"2002","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib55","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1098612X11429645","article-title":"Effect of pimobendan on the clinical outcome and survival of cats with non-taurine responsive dilated cardiomyopathy","volume":"14","author":"Hambrook","year":"2012","journal-title":"J\u00a0Feline Med Surg"},{"issue":"25","key":"10.1016\/j.cvsm.2023.05.016_bib56","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1161\/01.cir.0000437913.98912.1d","article-title":"Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association","volume":"128","author":"Ganesh","year":"2013","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cvsm.2023.05.016_bib57","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2460\/javma.2020.257.10.1041","article-title":"Assessment of PDK4 and TTN gene variants in 48 Doberman Pinschers with dilated cardiomyopathy","volume":"257","author":"Meurs","year":"2020","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.016_bib58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/eurheartj\/ehr260","article-title":"Genetics of inherited cardiomyopathy","volume":"33","author":"Jacoby","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cvsm.2023.05.016_bib59","first-page":"156","article-title":"Arrhythmogenic right ventricular cardiomyopathy in dogs","volume":"40","author":"Cunningham","year":"2022","journal-title":"J\u00a0Vet Cardiol"},{"issue":"9","key":"10.1016\/j.cvsm.2023.05.016_bib60","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.0000118494.07530.65","article-title":"Arrhythmogenic right ventricular cardiomyopathy causing sudden cardiac death in boxer dogs: a new animal model of human disease","volume":"109","author":"Basso","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cvsm.2023.05.016_bib61","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1292\/jvms.11-0080","article-title":"Pathological features of arrhythmogenic right ventricular cardiomyopathy in middle-aged dogs","volume":"73","author":"Nakao","year":"2011","journal-title":"J\u00a0Vet Med Sci"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib62","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/jvim.12385","article-title":"Natural history of arrhythmogenic right ventricular cardiomyopathy in the boxer dog: a prospective study","volume":"28","author":"Meurs","year":"2014","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5326\/JAAHA-MS-6550","article-title":"Clinical Features of English Bulldogs with Presumed Arrhythmogenic Right Ventricular Cardiomyopathy: 31 Cases (2001-2013)","volume":"54","author":"Cunningham","year":"2018","journal-title":"J\u00a0Am Anim Hosp Assoc"},{"issue":"15","key":"10.1016\/j.cvsm.2023.05.016_bib64","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1161\/01.CIR.102.15.1863","article-title":"Spontaneously occurring arrhythmogenic right ventricular cardiomyopathy in the domestic cat: A new animal model similar to the human disease","volume":"102","author":"Fox","year":"2000","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib65","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/jvim.12550","article-title":"Sudden death associated with QT interval prolongation and KCNQ1 gene mutation in a family of English Springer Spaniels","volume":"29","author":"Ware","year":"2015","journal-title":"J\u00a0Vet Intern Med"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.016_bib66","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00439-019-02020-w","article-title":"Personalized medicine: going to the dogs?","volume":"138","author":"Mealey","year":"2019","journal-title":"Hum Genet"},{"issue":"9","key":"10.1016\/j.cvsm.2023.05.016_bib67","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41569-021-00549-w","article-title":"Pharmacogenetics to guide cardiovascular drug therapy","volume":"18","author":"Duarte","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib68","doi-asserted-by":"crossref","first-page":"12522","DOI":"10.1038\/s41598-021-91372-3","article-title":"A\u00a0genetic polymorphism in P2RY(1) impacts response to clopidogrel in cats with hypertrophic cardiomyopathy","volume":"11","author":"Ueda","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.cvsm.2023.05.016_bib69","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.294.10.1224","article-title":"Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study","volume":"294","author":"Sabatine","year":"2005","journal-title":"JAMA"},{"issue":"9497","key":"10.1016\/j.cvsm.2023.05.016_bib70","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.cvsm.2023.05.016_bib71","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2023.05.016_bib72","first-page":"S306","article-title":"Secondary prevention of cardiogenic arterial thromboembolism in the cat: The double-blind, randomized, positive-controlled feline arterial thromboembolism; clopidogrel vs. aspirin trial (FAT CAT)","volume":"17","author":"Hogan","year":"2015","journal-title":"J\u00a0Vet Cardiol"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.016_bib73","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/jvim.14568","article-title":"Platelet Activation and Clopidogrel Effects on ADP-Induced Platelet Activation in Cats with or without the A31P Mutation in MYBPC3","volume":"30","author":"Li","year":"2016","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.016_bib74","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1160\/TH11-03-0202","article-title":"Prevalence of poor biological response to clopidogrel: a systematic review","volume":"107","author":"Mallouk","year":"2012","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/tpj.2015.17","article-title":"A\u00a0prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI study","volume":"16","author":"So","year":"2016","journal-title":"Pharmacogenomics J"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib76","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00228-017-2198-2","article-title":"Platelet receptor Gene (P2Y12, P2Y1) and platelet glycoprotein Gene (GPIIIa) polymorphisms are associated with antiplatelet drug responsiveness and clinical outcomes after acute minor ischemic stroke","volume":"73","author":"Yi","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib77","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/age.12666","article-title":"Nonsynonymous single nucleotide polymorphisms in candidate genes P2RY1, P2RY12 and CYP2C19 for clopidogrel efficacy in cats","volume":"49","author":"Ueda","year":"2018","journal-title":"Anim Genet"},{"issue":"12","key":"10.1016\/j.cvsm.2023.05.016_bib78","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2217\/pgs-2016-0056","article-title":"Genetic polymorphisms influence on the response to clopidogrel in peripheral artery disease patients following percutaneous transluminal angioplasty","volume":"17","author":"Diaz-Villamarin","year":"2016","journal-title":"Pharmacogenomics"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.016_bib79","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/cpt.2526","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022\u00a0Update","volume":"112","author":"Lee","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"19","key":"10.1016\/j.cvsm.2023.05.016_bib80","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1161\/CIRCULATIONAHA.109.851949","article-title":"Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes","volume":"119","author":"Mega","year":"2009","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.cvsm.2023.05.016_bib81","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2010.1543","article-title":"Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis","volume":"304","author":"Mega","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib82","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jvp.12717","article-title":"High interindividual variability in plasma clopidogrel active metabolite concentrations in healthy cats is associated with sex and cytochrome P450 2C genetic polymorphism","volume":"42","author":"Lee","year":"2019","journal-title":"J\u00a0Vet Pharmacol Ther. Jan"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib83","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/01.ATV.0000148708.44691.27","article-title":"Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP","volume":"25","author":"Hetherington","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.016_bib84","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.thromres.2006.02.006","article-title":"Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel","volume":"119","author":"Lev","year":"2007","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s40292-015-0120-5","article-title":"Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues","volume":"22","author":"Borghi","year":"2015","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.016_bib86","doi-asserted-by":"crossref","first-page":"H2021","DOI":"10.1152\/ajpheart.00647.2006","article-title":"Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigation","volume":"291","author":"Pfeffer","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib87","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/1074248416686188","article-title":"ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors","volume":"22","author":"Danilov","year":"2017","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.016_bib88","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1111\/jvim.16573","article-title":"Prevalence of aldosterone breakthrough in dogs receiving renin-angiotensin system inhibitors for proteinuric chronic kidney disease","volume":"36","author":"Ames","year":"2022","journal-title":"J\u00a0Vet Intern Med"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.016_bib89","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s41440-022-00913-4","article-title":"Aldosterone breakthrough from a pharmacological perspective","volume":"45","author":"Mogi","year":"2022","journal-title":"Hypertens Res"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib90","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10557-014-6537-6","article-title":"Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?","volume":"28","author":"Schilders","year":"2014","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib91","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/ajkd.2002.34489","article-title":"ACE genotype and ACE inhibitor response in kidney disease: a perspective","volume":"40","author":"Mayer","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib92","first-page":"197","article-title":"Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels","volume":"51","author":"Tiret","year":"1992","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib93","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/age.12260","article-title":"Polymorphisms in the canine and feline renin-angiotensin-aldosterone system genes","volume":"46","author":"Meurs","year":"2015","journal-title":"Anim Genet"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib94","article-title":"Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism","volume":"18","author":"Meurs","year":"2017","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib95","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40575-021-00105-2","article-title":"Prevalence of an angiotensin-converting enzyme gene variant in dogs","volume":"8","author":"Adin","year":"2021","journal-title":"Canine Med Genet"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib96","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/jvim.15746","article-title":"Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism","volume":"34","author":"Adin","year":"2020","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.016_bib97","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10741-008-9095-9","article-title":"Genomics, heart failure and sudden cardiac death","volume":"15","author":"Darbar","year":"2010","journal-title":"Heart Fail Rev"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.016_bib98","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10741-008-9094-x","article-title":"Beta-blocker pharmacogenetics in heart failure","volume":"15","author":"Shin","year":"2010","journal-title":"Heart Fail Rev"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.016_bib99","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1939-1676.2007.tb01949.x","article-title":"Carvedilol in dogs with dilated cardiomyopathy","volume":"21","author":"Oyama","year":"2007","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib100","first-page":"31","article-title":"Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial","volume":"3","author":"Kveiborg","year":"2007","journal-title":"Vasc Health Risk Manag"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib101","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s001090000080","article-title":"Beta1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy?","volume":"78","author":"Podlowski","year":"2000","journal-title":"J\u00a0Mol Med (Berl)"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.016_bib102","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/1755-5922.12030","article-title":"State of play of pharmacogenetics and personalized medicine in heart failure","volume":"31","author":"Parry","year":"2013","journal-title":"Cardiovasc Ther"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib103","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.rvsc.2013.02.021","article-title":"Identification of DNA variants in the canine beta-1 adrenergic receptor gene","volume":"95","author":"Maran","year":"2013","journal-title":"Res Vet Sci"},{"issue":"9","key":"10.1016\/j.cvsm.2023.05.016_bib104","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/FPC.0000000000000152","article-title":"Impact of the canine double-deletion beta1 adrenoreceptor polymorphisms on protein structure and heart rate response to atenolol, a beta1-selective beta-blocker","volume":"25","author":"Meurs","year":"2015","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.rvsc.2011.05.007","article-title":"Identification of beta-1 adrenergic receptor polymorphisms in cats","volume":"93","author":"Maran","year":"2012","journal-title":"Res Vet Sci"},{"issue":"17","key":"10.1016\/j.cvsm.2023.05.016_bib106","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1161\/01.CIR.0000099502.17776.C2","article-title":"Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension","volume":"108","author":"Michelakis","year":"2003","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.cvsm.2023.05.016_bib107","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.cvsm.2023.05.016_bib108","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.274.20.13729","article-title":"Cyclic GMP phosphodiesterase-5: target of sildenafil","volume":"274","author":"Corbin","year":"1999","journal-title":"J\u00a0Biol Chem"},{"issue":"8","key":"10.1016\/j.cvsm.2023.05.016_bib109","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1164\/ajrccm.165.8.2107097","article-title":"Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension","volume":"165","author":"Shekerdemian","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00395-004-0504-5","article-title":"Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells","volume":"100","author":"Tantini","year":"2005","journal-title":"Basic Res Cardiol"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.016_bib111","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1939-1676.2007.tb01947.x","article-title":"Sildenafil citrate therapy in 22 dogs with pulmonary hypertension","volume":"21","author":"Kellum","year":"2007","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib112","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1939-1676.2010.0517.x","article-title":"Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs","volume":"24","author":"Brown","year":"2010","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.016_bib113","first-page":"182","article-title":"Acute resolution of pulmonary alveolar infiltrates in 10 dogs with pulmonary hypertension treated with sildenafil citrate: 2005-2014","volume":"17","author":"Kellihan","year":"2015","journal-title":"J\u00a0Vet Cardiol"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib114","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00421-017-3761-3","article-title":"New pulmonary hypertension model in conscious dogs to investigate pulmonary-selectivity of acute pharmacological interventions","volume":"118","author":"Mondritzki","year":"2018","journal-title":"Eur J Appl Physiol"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/vms3.60","article-title":"Retrospective evaluation of pimobendan and sildenafil therapy for severe pulmonary hypertension due to lung disease and hypoxia in 28 dogs (2007-2013)","volume":"3","author":"Murphy","year":"2017","journal-title":"Vet Med Sci"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib116","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jvim.15679","article-title":"Clinical features and outcome in 25 dogs with respiratory-associated pulmonary hypertension treated with sildenafil","volume":"34","author":"Johnson","year":"2020","journal-title":"J\u00a0Vet Intern Med"},{"issue":"8","key":"10.1016\/j.cvsm.2023.05.016_bib117","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5414\/CP201496","article-title":"Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers","volume":"49","author":"Kanjanawart","year":"2011","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.cvsm.2023.05.016_bib118","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/FPC.0b013e32834b79e6","article-title":"The disposition of three phosphodiesterase type 5 inhibitors, vardenafil, sildenafil, and udenafil, is differently influenced by the CYP3A5 genotype","volume":"21","author":"Shon","year":"2011","journal-title":"Pharmacogenet Genomics"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib119","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.clpt.2005.08.005","article-title":"The CYP2C9 genotype does not influence sildenafil pharmacokinetics in healthy volunteers","volume":"78","author":"Jetter","year":"2005","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.016_bib120","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/tpj.2017.8","article-title":"CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction","volume":"18","author":"de Denus","year":"2018","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib121","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.ijir.3900802","article-title":"Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters","volume":"14","author":"Lin","year":"2002","journal-title":"Int J Impot Res"},{"issue":"49","key":"10.1016\/j.cvsm.2023.05.016_bib122","doi-asserted-by":"crossref","first-page":"41406","DOI":"10.1074\/jbc.M112.389189","article-title":"Identification of amino acid residues responsible for the selectivity of tadalafil binding to two closely related phosphodiesterases, PDE5 and PDE6","volume":"287","author":"Cahill","year":"2012","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib123","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jvim.12256","article-title":"Identification of PDE5A:E90K: a polymorphism in the canine phosphodiesterase 5A gene affecting basal cGMP concentrations of healthy dogs","volume":"28","author":"Stern","year":"2014","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib124","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1038\/s41598-019-43318-z","article-title":"Effect of a phosphodiesterase-5A (PDE5A) gene polymorphism on response to sildenafil therapy in canine pulmonary hypertension","volume":"9","author":"Ueda","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.cvsm.2023.05.016_bib125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fvets.2019.00022","article-title":"Translating Pharmacogenetics and Pharmacogenomics to the Clinic: Progress in Human and Veterinary Medicine","volume":"6","author":"Campion","year":"2019","journal-title":"Front Vet Sci"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.016_bib126","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1939-1676.1998.tb02107.x","article-title":"Calcium channel blockers in veterinary medicine","volume":"12","author":"Cooke","year":"1998","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib127","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1098612X211013736","article-title":"Dual therapy with clopidogrel and rivaroxaban in cats with thromboembolic disease","volume":"24","author":"Lo","year":"2022","journal-title":"J\u00a0Feline Med Surg"},{"issue":"9","key":"10.1016\/j.cvsm.2023.05.016_bib128","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.14202\/vetworld.2017.1072-1082","article-title":"N-terminal-pro brain natriuretic peptides in dogs and cats: A technical and clinical review","volume":"10","author":"de Lima","year":"2017","journal-title":"Vet World"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.016_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","article-title":"Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"10.1016\/j.cvsm.2023.05.016_bib130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14304\/SURYA.JPR.V4N7.5","article-title":"RNA therapeutics: RNAi and antisense mechanisms and clinical applications","volume":"4","author":"Chery","year":"2016","journal-title":"Postdoc J"},{"issue":"10","key":"10.1016\/j.cvsm.2023.05.016_bib131","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jgm.1609","article-title":"Gene delivery methods in cardiac gene therapy","volume":"13","author":"Ishikawa","year":"2011","journal-title":"J\u00a0Gene Med"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.016_bib132","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/01.CIR.101.4.408","article-title":"Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart : prospects for molecular ventricular assistance","volume":"101","author":"Shah","year":"2000","journal-title":"Circulation"}],"container-title":["Veterinary Clinics of North America: Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019556162300089X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019556162300089X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:51:00Z","timestamp":1759283460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019556162300089X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":132,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S019556162300089X"],"URL":"https:\/\/doi.org\/10.1016\/j.cvsm.2023.05.016","relation":{},"ISSN":["0195-5616"],"issn-type":[{"value":"0195-5616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Personalized Medicine in Companion Animal Cardiology","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Small Animal Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cvsm.2023.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}